Lantheus Medical Imaging Inc. and two medical isotope producers have agreed to work together to help ensure supplies of potentially life-saving nuclear medicine using molybdenum-99 (Mo-99) sourced from low enriched uranium (LEU).

W. L. Gore and Associates has announced the commercial availability of its new 10-cm configuration of the Gore Hybrid Vascular Graft. The new configuration allows for access to deeper vessels, which expands the treatable patient population and offers exceptional ease of use for physicians performing vascular procedures.

November 15, 2012 – GE Healthcare Canada announced Health Canada clearance of its new cardiac imaging platform, the Discovery* CT750 HD FREEdom Edition. Addressing the main challenges of cardiac imaging – coronary motion, calcium blooming, plaque composition and accurate myocardial perfusion – the FREEdom Edition is designed to provide a new level of cardiac CT performance.


November 20, 2012 — More than 570 providers identify McKesson, Merge, Philips and Siemens as the top vendors in terms of overall provider satisfaction and adoption, according to the recently released KLAS study, Cardiology IT 2012: Fitting the Pieces Together.


Medtronic Inc. announced the first treatment of a U.S. patient in its global, multicenter, randomized clinical trial comparing the Medtronic CoreValve system with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk to undergo open-heart surgery. The Medtronic CoreValve Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial is evaluating the minimally-invasive CoreValve system in less-sick patients who typically are treated with open-heart surgical aortic valve replacement today.

Biotronik announced that high profile medical centers across the country are implanting the new Evia HF-T triple-chamber cardiac resynchronization therapy (CRT) pacemaker.

Subscribe Now